• Title/Summary/Keyword: 재발율

Search Result 698, Processing Time 0.027 seconds

Experimental Study on Moisture Content According to Addition of Surfactants (계면활성제 첨가에 따른 함수율에 관한 실험적 연구)

  • Kim, Nam-Kyun;Rie, Dong-Ho
    • Fire Science and Engineering
    • /
    • v.29 no.2
    • /
    • pp.79-83
    • /
    • 2015
  • The fire accident is a representative type of disaster that can largely impact on business. Therefore, precautionary measures and rapid initial response is very important when a disaster occurs. The storage of porous combustibles is inevitable in coal yard, plywood processing industry, and others that are currently operating. Initial fire fighting of fire and identifying the ignition point in such a porous combustible storage space are so difficult that if the initial response is failed, being led to deep-seated fire, surface fire is likely to result in secondary damage. In addition, deep-seated fire can cause personal injuries and property damage due to a large amount of toxic gases and reignition. Therefore damage reduction measures is required around the storage space to handle a porous flammable. Improving the penetration performance of the concentration of the surfactant is carried out as underlying study, which is about an deep-seated fire extinguishing efficiency augmentation when using wetting agents. The porous materials used in the experiments is radiata pine wood flour, which occupies more than 75% of the domestic wood market. Fire fighting water is selected as Butyl Di Glycol (BDG), which is being used for infiltration extinguishing agent, and the experiment was carried out by producing a standard solution. The experiment was carried out on the basis of the Deep-Seated Fire Test of NFPA 18. The amount of watering, porous material to the internal amount of penetration, and runoff measurement out of the porous material was conducted. According to experimental results, as the surface tension is reduced, the surfactant concentration macroscopic penetration rate decreases, but infiltration to a porous material is shown to have growth characteristics.

Model Design for Successful Adoption of ERP Cost Management System (ERP 원가관리시스템의 성공적 도입을 위한 모형 설계)

  • 오은해;김창수;이재엽
    • Proceedings of the Korea Association of Information Systems Conference
    • /
    • 2004.11a
    • /
    • pp.349-365
    • /
    • 2004
  • 기업의 또는 부문에서 구축된 각 정보시스템들은 시간이 지남에 따라 기업의 경쟁우위를 확보하기 위해 통합의 필요성이 증대하게 되었는데, 이러한 필요에 의해 제기된 것이 ERP(Enterprise Resource Planning: 전사적 자원관리)이다. 급변하는 기업의 내${\cdot}$외부 환경에 대해 신속하게 대응하기 위해 ERP 시스템을 도입하는 기업들의 수가 증가함에도 불구하고 ERP 원가관리시스템에 대한 연구는 아직까지 그 범위가 한정되었다고 할 수 있다. 본 논문은 ERP 도입 현황 및 원가관리시스템의 도입${\cdot}$설계현황자료를 바탕으로 하여, 중소기업의 ERP 원가관리시스템의 성공적 도입을 위한 방향을 제시하고자 한다. 중소기업에서 ERP 원가관리시스템을 도입할 때는, 원가관리시스템의 특성과 구축 목표, 구조 설계, 원가대상 설정 등과 관련된 다음과 같은 사항들을 고려하여야 성공적인 시스템을 구축할 수 있을 것이다. 첫째, ERP 원가관리시스템 특성 분석단계에서는 원가정보를 구성하는 내용의 충실성뿐만 아니라 정보가 전달${\cdot}$제공되는 범위와 대상의 적합성과 함께 그 표현의 형식 또한 고려되어야 한다. 둘째, ERP 원가관리시스템 구축목표 설정단계에서는 인가관리정보의 산출요건에 대한 명확한 이해와 목표설정을 기반으로 해야 한다. 셋째, ERP 원가 관리시스템 구조 분석 및 선계단계에서는 생산관리시스템 및 원가대상 설정 분석이 이루어져야 한다. 넷째, ERP 원가관리시스템 구현단계에서는 원가관리시스템과 타 계열시스템과의 인터페이스를 고려해야 한다. 따라서 원가관리시스템의 구현 시에는 관련시스템에서 어떠한 정보론 인터페이스 받을 것인가를 명확히 하여 시스템 가동 시에 타 관련시스템과 원활한 연계가 되도록 함으로써 전사적 종합시스템이 되도록 하여야 학 것이다.RS와 제진장치에 대한 전체적인 성능평가를 성공적으로 수행하였으며, 운전결과 및 경험은 향후 상용설비를 위한 기본자료로 활용할 것이다.X>, 그리고 입원기간은 $21.6\pm14.3일(13\~56)$이었다. 수술 후 평균 CK-MB는 $11.3\pm14.1ng/mL$였다. 수술 후 조기 혈관 개존율은 $100\% (24/24)$였다. 모든 환자에서 완전 추적이 가능하였으며 평균 추적기간은 $20.4\pm15.2개월(5\~43)$이었다. 이 기간 중 사망환자나 흉통이 재발한 환자는 없었다. 걸론: 80세 이상 고령의 환자에서 OPCAB은 수술 후 합병증을 줄이고 좋은 결과를 보여 주었다. 그러므로 고령의 환자에서도 관상동맥우회술의 적응증이 되면 적극적으로 수술을 시행할 필요가 있으며, 수술방법은 OPCAB이 좋을 것으로 생각한다서 실용적 개발의 가능성을 보였다.에 따라 현저한 차이가 있었으며 Dimethoate처리$(30^{\circ}C,\; 0.2\%$액에서 24시간)에 의하여 볍씨의 호흡량이 감소되었다. 9) 산소호흡량과 평균발아소요일수와는 $\gamma=-0.945$로 부의 유의한 상관을 보였는데 산소호흡량이 많은 품종은 평균발아소요일수가 짧은 경향을 보였다. 10) 볍씨의 산소호흡량과 Dimethoate 처리에 의한 볍씨의 발아저해도와는 $\gamma=-0,771$의 높은 부의 상관을 보였으며 산색호흡량이 많은 품종이 발아저해도가 낮고 적은 품종에서는 높았다. 현재까지는 그 활동이 11.2년의 주기성을 보여주지만 그 이전에 있어서는 그 활동이 극히 약화되었을 뿐만 아니라 매우 불규칙하다는 것이 Schneider와 Mass(1975)에 의해 밝혀졌다. 결국 1710년대부터 현재까지 우리나라에 있어서 벼멸구와 흰

  • PDF

Inducing Apoptosis of NCI-H157 Human Lung Carcinoma Cells via Activation of Caspase Cascade by Combination Treatment with Arsenic Trioxide and Sulindac (NCI-H157 폐암 세포주에서 Caspase Cascade 활성을 통한 Arsenic Trioxide와 Sulindac 병합요법의 세포고사효과)

  • Kim, Hak Ryul;Yang, Sei Hoon;Jeong, Eun Taik
    • Tuberculosis and Respiratory Diseases
    • /
    • v.56 no.4
    • /
    • pp.381-392
    • /
    • 2004
  • Arsenic trioxide($As_2O_3$) was introduced into the treatment of refractory or relapsed acute promyelocytic Ieukemia. Some investigators have reported that arsenic trioxide had induced apoptosis in a variety of solid human tumor cell lines, including non-small cell lung cancer. Non-steroidal anti-inflammatory drugs(NSAIDs) are powerful chemopreventive agents for gastrointestinal cancers and the growth of established tumors are reduced by inducing apoptosis. It's also reported that NSAIDs enhanced tumor response to chemotherapeutic drugs or radiation. In this study, we aimed to determine whether combination of arsenic trioxide with sulindac augmented its apoptotic potential in NCI-H157 human lung cancer cells. The human lung cancer cell line NCI-H157 was treated with arsenic trioxide and sulindac. Cell viability was measured by the MTT assay. Apoptosis was measured by nuclear staining and flow cytometric analysis. The catalytic activity of the caspase families were measured by the fluorogenic cleavage of biosubstrates. The western blotting were also performed to define the mechanical basis of apoptosis. Combination treatment of arsenic trioxide and sulindac decreased the viability of NCI-H157 human lung cancer cells in a dose-dependent manner. The catalytic activity of caspase-3, 8 and 9 proteases were increased after combination treatment. Consistently PARP was cleaved from 116kDa to 85kDa fragments, and the expression of ICAD was decreased by time-dependent manner. Also combination treatment increased the expression of Fas and Fas/L. Combination therapy of arsenic trioxide with sulindac augments cell death and induces apoptosis via the activation of caspase cascade in NCI-H157 human lung carcinoma cells.

8 Cases of Partial Laryngectomy (최근 경험한 후두부분절제술 8예)

  • 유홍균;김명진;이상학;신홍수
    • Proceedings of the KOR-BRONCHOESO Conference
    • /
    • 1983.05a
    • /
    • pp.14.4-15
    • /
    • 1983
  • The laryngeal carcinoma is the most frequent malignant tumor in the E.N.T. field. In the surgical treatment of laryngeal carcinoma, in 1873, Billroth performed the first total laryngectomy, and in 1863, H. B. Sands performed the first partial laryngectomy. Recently general advances (antibiotic therapy, blood trasfusion, and safer anesthesia) result in the improvement of postoperative prognosis. Because the laryngeal lymphatic system has the characteristic compartmentation, this serves the anatomic basis for performing the partial laryngectomy. Although the indications of partial laryngectomy are different from that of total laryngectomy, the partial laryngectomy has the advantage of not only removal of all malignant disease, but also maximum preservation of respiratory, phonatory, and sphincteric function of the larynx. In the latest, surgical treatment decreased the frequency of recurrence, and also increased the 5 year survival rate with combination of the chemotherapy and radiation therapy. The authors have experienced 8 cases of partial laryngectomy for laryngeal carcinoma at the department of otolaryngology, Korea University Hospital from 1980 to 1982. Among the total 8 cases, 2 cases were involved only in the epiglottis, 2 cases in the anterior 1/3 of both vocal cords with ant. comissure, 2 cases in the middle 1/3 of Lt. vocal cord, 1 case in the anterior 1/3 of Rt. vocal cord with ant. comissure, and another 1 case in the Rt. ventrical. So authors report these cases with review of the literature.

  • PDF

A Study on the Repair of Fatigue Damage at Large Cast Iron structure using Cold Joint Method (냉간체결방법을 이용한 대형 주철 구조물의 피로손상수리방법에 대한 연구)

  • Lee, Sung-Riong;Lee, Dong Jun;Cho, Seok Swoo
    • Journal of the Korea Academia-Industrial cooperation Society
    • /
    • v.20 no.10
    • /
    • pp.140-148
    • /
    • 2019
  • Large cast iron structures are used in casings and pipes in shipsand chemical plants. Broken parts in the casings and pipescan result in failures even when stresses are below the yield strength of the part's materials. Fatigue failure of a large cast iron structure is inevitable due to the design constraints and low reliability of the material strength. A small structure can be repaired by welding, but a large structure cannot because it cannot be preheated slowly and uniformly. This study shows that a large structure can be repaired by a cold joint method using a crack repair screw. Large cast iron structures were manufactured by GC 300, and their design stress is below 3.5 MPa. The tensile strength on notched specimens repaired by crack repair screws was 8.2 MPa. Therefore, the safety factors of structures repaired by crack repair screws have a value above 2.3 and are considered to be high values.

Application of Molecular Diagnostics Technology in the Development of a Companion Diagnostics for Malignant Solid Tumors (악성 고형암의 항암제 동반진단 기술에서 분자진단기술의 적용)

  • Kim, Jin-Hee
    • The Journal of the Korea Contents Association
    • /
    • v.19 no.3
    • /
    • pp.365-374
    • /
    • 2019
  • Unlike benign tumors, malignant tumors are capable of metastasis, easy to relapse, poor survival, and low quality of life. In Korea, here is a tendency to treat the tumors collectively according to the General Principles of Cancer Chemotherapy(GPCC) of the Health Insurance Review & Assessment Service (HIRA). But recently, companion diagnostics(CDx) is recommended rather than unilateral medication because biomarker-based molecular diagnostics is possible to predict the drug response of patients before drug treatment. Not only domestic but also overseas Food and Drug Administratio (FDA) recommends the development of the CDx system at the stage of drug development to ensure the responsiveness and safety of medicines. In this study, I focused on the necessity of CDx development direction as well as CDx development status through literature review. Furthermore I also discussed CDx types according to the molecular diagnostic technology such as immunohistochemistry (IHC), polymerase chain reaction (PCR), in situ hybridization (ISH), and next-generation sequencing (NGS) not only in the approved CDx but also in the developing one by US FDA. And I suggested the technology issue of CDx development process such as a selection of molecular diagnostics at the time of release, a clear understanding of the CDx mechanism, and a convergence of drug with CDx development. The necessity of social insurance system also was proposed for CDx development.

A Case of Metastatic Ampulla of Vater Cancer Treated with Chemotherapy Followed by Pylorus Preserving Pancreaticoduodenectomy (항암화학요법과 수술을 통해 완전 관해를 획득한 진행성 십이지장 유두암 증례)

  • Hae Ryong Yun;Moon Jae Chung;Seungmin Bang;Seung Woo Park;Si Young Song
    • Journal of Digestive Cancer Research
    • /
    • v.2 no.2
    • /
    • pp.75-77
    • /
    • 2014
  • Ampulla of Vater (AOV) cancer is rare malignant tumor which arises within the vicinity of the AOV. Metastatic AOV adenocarcinoma has poor prognosis, with an overall survival rate at 2 years ranging from 5 to 10%. The Surveillance, Epidemiology and End Results Program of the National Cancer Institute indicated that lymph node metastasis was present in as many as half of patients which were associated with poor prognosis and liver was the second most common site of distant metastasis in AOV cancer. In this case report, we describe a case of complete resolution of AOV cancer, which was already spread to retroperitoneal lymph node and liver. The patient underwent gemcitabine plus cisplatin chemotherapy for palliative aim. After 12 month of chemotherapy, image study showed partial remission, so intraoperative radiofrequency ablation therapy and pylorus preserving pancreaticoduodenectomy was done. AOV cancer was completely resected and the patient was followed up without recurrence for 7 months.

  • PDF

Imaging Findings of Metaplastic Breast Carcinoma with Chondroid Differentiation: A Case Reports (연골성 분화를 보이는 화생성 유방암의 영상의학적 소견: 증례 보고)

  • Ji-Young Kim;Soung Hee Kim;Myeong Ja Jeong;Ji Hae Lee;Mi-Jin Kang;Geumhee Gwak;Su Hyun Yoo
    • Journal of the Korean Society of Radiology
    • /
    • v.83 no.6
    • /
    • pp.1385-1393
    • /
    • 2022
  • Metaplastic carcinoma of the breast is a heterogeneous group of neoplasms with mixed epithelial and mesenchymal differentiation. Metaplastic carcinoma of the breast is a rare and aggressive malignancy, with high recurrence and metastasis. Metaplastic carcinoma with chondroid differentiation is an uncommon subtype that tends to have a relatively good prognosis than that of other subtypes. We report the imaging features of three cases of pathologically proven metaplastic carcinoma with chondroid differentiation as follows: a high-density mass with amorphous or coarse heterogeneous calcifications on mammography; a microlobulated or partially indistinct, complex cystic, and solid mass on sonography; and a relatively circumscribed or partially indistinct, irregular mass with heterogeneous T2 high-signal intensity and heterogeneous or rim enhancement with initial fast enhancement and delayed washout on MRI.

The Results of Combined External Radiotherapy and Chemotherapy in the Management of Esophageal Cancer (식도암의 방사선-항암화학 병용치료결과)

  • Lee Hyun Joo;Suh Hyun Suk;Kim Jun Hee;Kim Chul Soo;Kim Sung Rok;Kim Re Hwe
    • Radiation Oncology Journal
    • /
    • v.14 no.1
    • /
    • pp.17-23
    • /
    • 1996
  • Purpose : To evaluate the role of combination therapy of external radio-therapy and chemotherapy in the management of advanced esophageal cancer as a primary treatment compared with radiation therapy alone. Materials and Methods : A retrospective review of evaluable 55 esophageal cancer patients referred to the Department of Therapeutic Radiology, Paik Hospital for the external radiotherapy between Jul, 1983 and Dec. 1994 was undertaken. Combined therapy patients (A group) were 30 and radiation alone patients (B group) were 25. Median age was 60 years old in A group (ranges : 42-81) and 65 years old in B group (ranges : 50-81). The male patients were 53. The fifty patients had squamous cell carcinomas. Radiation doses of 2520-6480c0y were delivered over a period of 4-7weeks, using 4MV LINAC. Chemotherapy was administered in bolus injection before, after, or during the course of external radiotherapy. The local control rate and patterns of failure according to both treatment modalities and 1, 2 year survival rates according to prognostic factors (stage, tumor length, radiation dose etc.) were analysed. Resuts : Median follow up Period was 7 months (range : 2-73 months). Median survival was 7.5 months (20 days-29 months) in A group and 5 months (20 days-73 months) in B group. The 1, 2 YSRs were $26.7\%$, $8.9\%$ in A group, $12.7\%$, $4.3\%$ in B group (p>0.05), respectively. The 1, 2 YSRs according to stage(II/III), tumor length (5cm more or less). radiation dose (5000cGymore or less) of A and B group were analyzed and the differences of survival rates of both treatments were not statistically significant. But among group B, patients who received 5000cGy or more showed significant survival benefits (p<0.05). The treatment response rates of A and B group were $43.8\%$. $25.0\%$, respectively. Complete response rate of $25.0\%$ in A and $8.3\%$ in B were achieved. The local failure and distant metastsis were $52.4\%$. $23.8\%$ in A group, $64.3\%$, $14.3\%$ in 8 group, respectively. The combination therapy revealed more frequent leukopenia and nausea/vomiting than radiation alone group, but degree of side effects was only mild to moderate. Conclusion : The combined external radiotherapy and chemotherapy for advanced esophageal cancer appears to improve the response rate, local control rate and survival rate, but the improvement was not statistically significant. The side effects of combined modalities were mild to moderate without significant morbidity. Therefore it may be worthwhile to continue the present combined external radiotherapy and chemotherapy in the management of advanced esophageal cancer to confirm our result.

  • PDF

Treatment Result of Ovarian Dysgerminoma (난소 미분화배세포종에 대한 방사선치료 결과)

  • Shin Seong Soo;Park Suk Won;Shin Kyung Hwan;Ha Sung Whan
    • Radiation Oncology Journal
    • /
    • v.15 no.4
    • /
    • pp.379-385
    • /
    • 1997
  • Purpose : Ovarian dysgerminoma is a highly radiosensitive malignant tumor occurring in young age group. The conventional treatment was total abdominal hysterectomy and bilateral salpingo-oophorectomy followed by radiotherapy. We retrospectively analyzed the treatment results of Patients who had received radiotherapy in the era before chemotherapy was widely used. Material and Method : Twenty two patients with ovarian dysgerminoma were treated at the Department of Therapeutic Radiology, Seoul National University Hospital between August, 1980 and May, 1991. Four patients were excluded from this study, because three patients received incomplete treatment and one received combined chemotherapy. Sixteen patients received postoperative radiotherapy and two patients had radical radiotherapy as tumor was unresectable. Median follow-up period was 99 months (range, 51-178) Median age was 22 years (range, 11-42). Among the postoperatively treated patients, three Patients were in stage IA, eight in stage IC, two in stage II, and three in stage III. One patient had Turner's syndrome. Radiotherapy was performed with high energy photon (telecobalt unit or linear accelerator, either 6MV or 10MV), The radiation dose to the whole abdomen was 1950-2100cGy (median, 2000) and 1050-2520cGy was added to the whole pelvis, the total dose to the whole pelvis was 3000-4500cGy (median, 3500). Prophylactic Paraaortic area irradiation was done in six Patients (dose range, 900-1500cGy). One patient who had positive Paraaortic node, received radiation dose of 1620cGy, followed by additional 900cGy to the gross mass with shrinking field. Total dose to the paraaortic node was 4470cGy. Six patients, including one who had paraaortic node metastasis, received Prophylactic irradiation to mediastinum and supraclavicular area (2520cGy). Of the two patients with unresectable tumors who received radical radiotherapy, one was in stage III and the other was in stage IV with left supraclavicular lymph node metastasis. The stage III patient received radiation to the whole abdomen (2000cGy), followed by boost to whole pelvis (2070cGy) and paraaortic area (2450cGy). Stage IV patient received radiation to the whole abdomen (2000cGy), followed by radiation to the whole pelvis and paraaortic area (2400cGy), mediastinum (2520cGy) , and left supraclavicular area (3550cGy) .Results : The 5 year local control rate was $100\%$ in patients who received postoperative adiuvant radiotherapy after total abdominal hysterectomy and bilateral salpingo-oophorectomy. Only one patient in stage III who did not receive prophylactic irradiation to mediastinum developed mediastinal metastasis. but was salvaged by chemotherapy. So. the 5 year overall survival rate uras also $100\%$. Two patients who received radiation only, are alive without disease at 112 and 155 months. Conclusion : Postoperntive adjuvant radiotherapy as well as radical radiotherapy in unresectable ovarian dysgerminoma was very effective. aut chemotherapy is also an effective treatment modality We now recomrneifd chemotherapy for Patients who need to save their ovarian functien and reserve radiotherapv fov chemo-resistant tumor or recurrence alter che motherapy.

  • PDF